Oralline
Sodium Fluoride
J.m. Murray Center Inc.
Human Otc Drug
NDC 55873-002Oralline also known as Sodium Fluoride is a human otc drug labeled by 'J.m. Murray Center Inc.'. National Drug Code (NDC) number for Oralline is 55873-002. This drug is available in dosage form of Gel, Dentifrice. The names of the active, medicinal ingredients in Oralline drug includes Sodium Fluoride - .15 g/100g . The currest status of Oralline drug is Active.
Drug Information:
| Drug NDC: | 55873-002 |
| The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC. |
| Proprietary Name: | Oralline |
| Also known as the trade name. It is the name of the product chosen by the labeler. |
| Product Type: | Human Otc Drug |
| Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing. |
| Non Proprietary Name: | Sodium Fluoride |
| Also known as the generic name, this is usually the active ingredient(s) of the product. |
| Labeler Name: | J.m. Murray Center Inc. |
| Name of Company corresponding to the labeler code segment of the ProductNDC. |
| Dosage Form: | Gel, Dentifrice |
| The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources. |
| Status: | Active |
| FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved. |
| Substance Name: | SODIUM FLUORIDE - .15 g/100g
|
| This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted. |
| Route Details: | ORAL
|
| The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
Marketing Information:
An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
| Marketing Category: | OTC MONOGRAPH FINAL |
| Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
| Marketing Start Date: | 01 Jan, 1966 |
| This is the date that the labeler indicates was the start of its marketing of the drug product. |
| Marketing End Date: | 10 May, 2026 |
| This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached. |
| Application Number: | part355 |
| This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null. |
| Listing Expiration Date: | 31 Dec, 2023 |
| This is the date when the listing record will expire if not updated or certified by the firm. |
OpenFDA Information:
An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
| Manufacturer Name: | J.M. Murray Center Inc.
|
| Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC. |
| RxCUI: | 416783
|
| The RxNorm Concept Unique Identifier. RxCUI is a unique number that describes a semantic concept about the drug product, including its ingredients, strength, and dose forms. |
| Original Packager: | Yes
|
| Whether or not the drug has been repackaged for distribution. |
| UPC: | 0652705419986
|
| UPC stands for Universal Product Code. |
| UNII: | 8ZYQ1474W7
|
| Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information. |
Packaging Information:
| Package NDC | Description | Marketing Start Date | Marketing End Date | Sample Available |
|---|
| 55873-002-01 | 85 g in 1 TUBE (55873-002-01) | 01 Jan, 1966 | N/A | No |
| Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together. |
Purpose:
Purpose anticavity toothpaste
Product Elements:
Oralline secure sodium fluoride sodium fluoride fluoride ion sorbitol hydrated silica water glycerin polyethylene glycol 600 sodium lauryl sulfate carboxymethylcellulose sodium sodium benzoate sodium phosphate, dibasic, dihydrate saccharin sodium fd&c blue no. 1 mint flavor oralline sodium fluoride sodium fluoride fluoride ion sorbitol hydrated silica water glycerin polyethylene glycol 600 sodium lauryl sulfate carboxymethylcellulose sodium sodium benzoate sodium phosphate, dibasic, dihydrate saccharin sodium titanium dioxide fd&c blue no. 1 mint flavor
Indications and Usage:
Use use - helps protect against cavities
Warnings:
Warnings if you accidentally swallow more than used for brushing get medical help or contact a poison control center immediately.
Dosage and Administration:
Directions adults and children 2 years of age and older. brush teeth thoroughly, preferably after each meal or at least twice a day or as directed by a dentist or doctor. children under 6 years of age. use a pea-sized amount and instruct in good brushing and rinsing habits to reduce swallowing. supervise children as necessary until capable of using without supervision.
Package Label Principal Display Panel:
Product labels oraline fluoride toothpaste ada accepted.the ada council on scientific affairs acceptance of oraline fluoride mint toothpaste is based on finding that the product is effective in helping to prevent and reduce tooth decay when used as directed no animal based ingredients. mint flavor net wt 3 oz (85 g) res murray_oraline_fluoride murray_oraline_fluoride_clear